Jan Dürig

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Total Hip Arthroplasty

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Annals of hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Othman Al-Sawaf, Karl-Anton Kreuzer, Anna Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Final analysis of the CLL2-GIVe trial (obinutuzumab, ibrutinib, and venetoclax) in untreated CLL with del(17p)/TP53mut. Blood (2023)
Olivier Hermine, Linmiao Jiang, Jan Walewski, André Bosly, Catherine Thieblemont, Michal Szymczyk, Christiane Pott, Gilles Andre Salles, Pierre Feugier, Kai Hübel, Corinne Haioun, René-Olivier Casasnovas, Christian Schmidt, Kamal Bouabdallah, Vincent Ribrag, Lothar Kanz, Jan Dürig, Bernd Metzner, David Sibon, Morgane Cheminant, Barbara Burroni, Wolfram Klapper, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Martin Dreyling, null null
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jan Dürig, Jens Uhlig, Anke Gerhardt, Markus Ritter, Gunnar Hapke, Jörg Heßling, Peter Staib, Frieder Wolff, Katja Krumm, Ludwig Fischer von Weikersthal
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale. Cancer medicine (2022)
Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias Karl Mai, Marc S Raab, Hans J Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Muller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Bone Marrow and Peripheral Blood Aberrant Plasma Cell Assessment by Next-Generation Flow Cytometry in MM Patients. Blood advances (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Benedikt W Pelzer, Marina Arendt, Susanne Moebus, Lewin Eisele, Karl-Heinz Jöckel, Ulrich Dührsen, Jan Dürig, null null
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis. Annals of hematology 97 (8) (2018)